gainbot
BriefMoversScreensSectorsEarningsIPOsNewsDividends & splitsScreenerWatchlistLearn
NASDAQ · SCNXHealthcarePharmaceuticals

Scienture Holdings, Inc. Common Stock (SCNX)

$3.42−0.87%
Close Nov 4, 2026 · split-adjusted
Oct 30, 2026$3.22▼ 83.40% in range
Oct 31, 2025Low $2.77 · High $99.25Oct 30, 2026
What changed · written from our data
As of Nov 4, 2026

Scienture Holdings closed at $3.42 on Nov 4, down 0.87%, 96.6% below its 52-week closing high. Volume of 14.2K shares was 0.23× its 20-day average (below normal).

Split-adjusted performance: -9.0% over one month, -65.0% over six months, -80.7% over one year.

In the quarter ended Jun 30, 2026, revenue was $343.64K, with a net margin of -821.3%.

Short interest was 105.9K shares at the Oct 15 settlement, down 91.9% from the prior report (0.3% of float, 1.0 days to cover).

Market cap$5.6M1.6M shares
Revenue · quarter$343.6K—
Diluted EPS$-1.75—
P/E · TTM—
Net margin-821.3%Gross 97.7%
Dividend yieldNone
52-week range2.77 – 99.25−96.6% from high
Volume14.2K0.23× 20-day avg
Volatility · 60d933.5%Annualised
Short % of float0.3%1.0 days to cover
Net cash-$1.4MCash $8.2M
Next earnings—Not scheduled
Split-adjusted performance
1W +0.6%1M −9.0%3M −63.3%6M −65.0%YTD −73.2%1Y −80.7%3Y —5Y —

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Pharmaceuticals

Percentile among 420 companies (100 = best)

6-month momentum16
Revenue growth—
Net margin24
Value (low P/E)—
Size9

Industry medians: 6-month return −25.5%, revenue growth +6.2%, net margin −33.8%, P/E 16.1×.

Short interest

Details →
Shares short105.9K−91.9% vs prior
Days to cover1.0Settled Oct 15
% of float0.3%
Short vol. 10d42.8%of daily volume

Closest peers by size in Pharmaceuticals

CompanyPriceToday6MRev. growthNet marginP/EMkt cap
SCNXScienture Holdings$3.42−0.87%−65.0%—−821.3%—$5.6M
ACXPAcurx Pharmaceuticals$1.03+0.98%−50.7%———$5.6MCompare
LGVNLongeveron$1.780.00%−79.6%−9.2%−2116.0%—$5.7MCompare
PULMPulmatrix$1.52+14.29%+11.8%———$5.6MCompare
PCSAProcessa Pharmaceuticals$1.94−0.26%−29.6%———$5.4MCompare
IMNNImunon$0.9070+0.78%−66.5%———$5.1MCompare
SKYESkye Bioscience$1.14−6.56%−83.3%———$5.0MCompare
CNSPCNS Pharmaceuticals$4.34−4.62%−37.1%———$6.3MCompare
APREAprea Therapeutics$0.5052−1.90%−39.4%−100.0%——$6.4MCompare

News about Scienture Holdings

All news →

No recent articles focused on Scienture Holdings.

Quick answers

What does Scienture Holdings do?
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on the commercialization and development of products for the treatment of cardiovascular (CVS) and Central Nervous System (CNS) diseases.
What is SCNX's market cap?
$5.62M, based on the Nov 4 close of $3.42.
Does Scienture Holdings pay a dividend?
No regular cash dividend has been paid in the last year.
How much of SCNX is sold short?
105.9K shares, 0.3% of float, as of Oct 15, 2026.
What sector is SCNX in?
Healthcare, in the Pharmaceuticals industry.

About Scienture Holdings

Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on the commercialization and development of products for the treatment of cardiovascular (CVS) and Central Nervous System (CNS) diseases. Scienture LLC launched its first commercial product for hypertension and is in the process of commercializing its second product for the treatment of opioid overdose. Its development pipeline consists of a broad range of novel product candidates including new potential treatments for migraine, thrombosis, pain and other related disorders.

HQ: Commack, NY9 employeesListed Feb 22, 2008scienture.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology